Skip to main content
. 2012 Aug 26;3(4):147–157. doi: 10.4021/wjon551w

Table 3. Risk Factor Analysis for Progression Free Survival.

Variable Univariate
Multivariate
Hazard ratio 95% CI P value Hazard ratio 95% CI P value
Disease stage DS
IIA vs IA 0.884 0.292 - 2.675 0.8274 1.166 0.342 - 3.972 0.8058
IIIA vs IA 1.337 0.465 - 3.845 0.2898 1.722 0.575 - 5.157 0.3311
IIIB vs IA 1.439 0.420 - 4.930 0.3350 4.219 0.994 - 17.902 0.0509
Disease stage ISS
II vs I 1.467 0.800 - 2.692 0.2156 1.41 0.699 - 2.845 0.3376
III vs I 0.742 0.304 - 1.808 0.5110 0.533 0.189 - 1.508 0.2358
Cytogenetics/FISH
3 vs 1 1.178 0.496 - 2.797 0.7107 0.997 0.391 - 2.44 0.9598
2 vs 1 1.750 0.483 - 6.254 0.3894 2.411 0.638 - 9.109 0.1943
Negative vs Positive conventional
skeletal survey
0.522 0.253 - 1.077 0.0784 0.396 0.172 - 0.910 0.0291
Gender
Male vs Female 0.998 0.577 - 1.726 0.9944 1.088 0.603 - 1.963 0.7795
Age 1.005 0.977 - 1.033 0.7452 1.005 0.973 - 1.039 0.7534

Abbreviations: DS: Durie-Salmon stage; ISS: International staging system; FISH: fluorescence in situ hybridization; Definitions of cytogenetics: 1-poor prognosis, complex abnormalities with del 13, 17p, or t(4:14), or any of these abnormalities; 2- Intermediate prognosis, normal chromosomes, Del 13 by FISH only; 3- Good prognosis, hyperdiploidy, t(11,14).